Ulrich Haupts (Scil Proteins GmbH)

Haupts, Ulrich (Coral BioNet 201109– CSO of Scil Proteins GmbH before Bayer + Direvo Biotech + SKB UK)

	Product	mass spectrometry (MS)

Scil Proteins GmbH. (9/13/11). "Press Release: Scil Proteins Appoints Chief Scientific Officer". Halle (Saale).

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, today announced that it has appointed Dr. Ulrich Haupts as its new Chief Scientific Officer. As of 1st October, Dr. Haupts will replace Scil Proteins' previous CSO, Dr. Arnd Steuernagel.

Dr. Haupts joins Scil Proteins from Bayer Healthcare, where he has held the position of Director of Protein Optimization for the last three years. His main responsibilities in this position included managing all efforts in lead optimization with a primary focus on antibody optimization and assay development. Prior to that, he spent seven years at Direvo Biotech (which was subsequently acquired by Bayer Schering Pharma in 2008) as Department Head of Assay Development and later, as Vice President of R&D Biopharmaceuticals. In addition, Dr. Haupts also worked for three years at SmithKline Beecham UK in the New Assay Technology group. Dr. Haupts received his PhD in 1996 from the Max-Planck Institute for Biochemistry in Martinsried, Germany and performed a two-year post-doctoral fellowship at Cornell University working in the field of mass spectrometry and fluorescence correlation spectroscopy.

"Ulrich brings with him considerable knowledge and expertise in the areas of protein optimization and assay development as well as in R&D from both the perspective of enterprising biotech and established pharma. His experience will be a significant addition to the leadership team as Scil Proteins works to further develop its integrated business model in drug discovery and protein manufacturing," said Dr. Ulrike Fiedler, CEO of Scil Proteins.

Commenting on his own appointment, Dr. Haupts noted: "I am truly excited to be joining such a leading company in the field of recombinant proteins and I look forward to working with the team in order to further develop the Company's Affilin®therapeutics platform."

Record changed: 2011-12-12

Follow Us!

Top News

Upcoming Events

Associations

Partners

Ulrich Haupts (Scil Proteins GmbH)

Scil Proteins GmbH. (9/13/11). "Press Release: Scil Proteins Appoints Chief Scientific Officer". Halle (Saale).

More documents for Ulrich Haupts